Clinical Trial Update: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

View source ↗

Summary

This completed NCI clinical trial reports on predictors of relapse in fallopian tube cancer, peritoneal cancer, and epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Peritoneal Neoplasms | Status: COMPLETED